ESPERION THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.9 USD | -4.52% |
|
-2.56% | -36.45% |
| Mar. 25 | Esperion Shares Continue Rise After Friday's FDA Approval for Nexlizet, Nexletol | DJ |
| Mar. 25 | Sector Update: Health Care Stocks Steady Premarket Monday | MT |
Chart calendar Esperion Therapeutics, Inc.
3c4a1be2b995897f1e7b990.9gCfVTj5saGXvHA56wKDapjfapKC1BAOEONmwTcyWhA.sFHIYwGwwvb17DZ0gGq0E6yYKM3ugF12ZpMc81J4GU_GUvkkaMvn786RQA~8bb1d9e5226ecae10786c7f45e4486d7
Upcoming events on Esperion Therapeutics, Inc.
Past events on Esperion Therapeutics, Inc.
| 2024-04-09 12:45 pm | Needham Healthcare Conference |
| 2024-03-25 08:00 am | NEXLETOL® and NEXLIZET® FDA Approval Call |
| 2024-02-27 08:00 am | Q4 2023 Earnings Call |
| 2024-02-27 06:00 am | Q4 2023 Earnings Release |
| 2024-01-10 05:15 pm | JPMorgan Healthcare Conference |
| 2023-11-14 03:00 am | Jefferies London Healthcare Conference |
| 2023-11-07 08:00 am | Q3 2023 Earnings Call |
| 2023-11-07 06:00 am | Q3 2023 Earnings Release |
| 2023-09-11 03:00 pm | H.C. Wainwright Global Investment Conference |
| 2023-08-26 11:00 am | European Society of Cardiology Congress |
| 2023-08-26 10:30 am | European Society of Cardiology Congress |
| 2023-08-07 09:00 am | BTIG Virtual Biotechnology Conference |
| 2023-08-01 08:00 am | Q2 2023 Earnings Call |
| 2023-08-01 06:00 am | Q2 2023 Earnings Release |
| 2023-07-23 10:40 am | ASPC Congress |
| 2023-07-22 02:35 pm | ASPC Congress |
| 2023-07-21 11:35 am | ASPC Congress |
| 2023-07-21 07:00 am | ASPC Congress |
| 2023-07-20 02:00 pm | ASPC Congress - Poster No 136 |
| 2023-06-24 08:40 pm | American Diabetes Association Scientific Session |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 148 148 0.18% | 228 230 -1.24% | 78,4 77,8 0.83% | 75,5 77,2 -2.24% | 116 113 3.19% | 265 |
|
EBITDA Million USD | Released Forecast Spread | -92,8 -101 7.9% | -121 -117 -3.59% | -226 -241 6.18% | -179 -183 2.02% | -155 -160 2.88% | -94,7 |
|
EBIT Million USD | Released Forecast Spread | -93,1 -104 10.28% | -121 -120 -1.17% | -227 -245 7.35% | -180 -184 2.68% | -156 -156 0.09% | -16,4 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -97,2 -109 11.11% | -144 -136 -5.55% | -269 -291 7.45% | -234 -237 1.31% | -209 -208 -0.4% | -67,1 |
|
Net income Million USD | Released Forecast Spread | -97,2 -111 12.22% | -144 -141 -2.15% | -269 -291 7.44% | -234 -237 1.43% | -209 -209 0.12% | -69,5 |
|
EPS USD | Released Forecast Spread | -3,59 -4,08 12.03% | -5,23 -5,05 -3.59% | -9,31 -10,1 7.76% | -3,52 -3,64 3.21% | -2,03 -2,03 -0.13% | -0,40 |
| Announcement Date | 27/02/20 | 23/02/21 | 22/02/22 | 21/02/23 | 27/02/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 S1 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 15,4 14,5 6.35% | 18,8 15,4 22.26% | 18,8 18,6 1.2% | 19,0 19,7 -3.57% | 18,8 20,6 -8.67% | 24,3 22,0 10.75% | 25,8 24,6 4.66% | 50,1 47,2 6.29% | 34,0 30,1 12.68% | 32,3 28,7 12.36% | 84,5 | 42,5 | 68,5 | 69,8 | 79,0 |
|
EBITDA Million USD | Released Forecast Spread | -55,5 -70,6 21.37% | -42,8 -48,3 11.28% | -52,2 -45,1 -15.79% | -41,5 -46,9 11.41% | -42,4 -44,9 5.46% | -48,5 -40,7 -19.22% | -37,0 -47,4 21.91% | -27,5 -31,5 12.68% | -42,4 -57,1 25.81% | -39,5 | -34,3 | -16,3 | -4,60 | ||
|
EBIT Million USD | Released Forecast Spread | -55,6 -70,9 21.49% | -43,0 -45,9 6.34% | -52,4 -43,6 -20.18% | -41,6 -45,4 8.34% | -42,5 -45,9 7.38% | -48,6 -39,1 -24.27% | -37,1 -41,4 10.44% | -27,5 -33,6 18.06% | -42,4 -40,1 -5.57% | 31,7 | -24,0 | -5,09 | -12,6 | 12,4 | |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -65,1 -83,1 21.59% | -56,7 -57,1 0.64% | -66,3 -56,5 -17.34% | -55,1 -59,6 7.46% | -55,5 -58,6 5.31% | -61,7 -52,5 -17.54% | -49,9 -54,3 7.99% | -41,3 -42,8 3.62% | -56,3 -55,5 -1.55% | 5,20 | -39,2 | -16,2 | -18,1 | -2,50 | |
|
Net income Million USD | Released Forecast Spread | -65,1 -83,0 21.58% | -56,7 -57,3 1% | -66,3 -56,5 -17.34% | -55,1 -59,7 7.67% | -55,5 -59,6 6.83% | -61,7 -52,5 -17.54% | -49,9 -54,4 8.21% | -41,3 -44,9 8.09% | -56,3 -56,6 0.47% | 7,47 | -38,2 | -19,4 | -23,9 | -2,50 | |
|
EPS USD | Released Forecast Spread | -1,77 -2,29 22.69% | -0,93 -1,04 10.84% | -1,05 -0,92 -13.59% | -0,81 -0,93 12.62% | -0,76 -0,85 10.91% | -0,79 -0,65 -21.04% | -0,46 -0,61 24.73% | -0,37 -0,43 13.45% | -0,50 -0,48 -3.74% | 0,05 | -0,21 | -0,10 | -0,13 | -0,01 | |
| Announcement Date | 22/02/22 | 03/05/22 | 02/08/22 | 01/11/22 | 21/02/23 | 09/05/23 | 01/08/23 | 01/08/23 | 07/11/23 | 27/02/24 | - | - | - | - | - |
More events
Past sector events for Esperion Therapeutics, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- ESPR Stock
- Calendar Esperion Therapeutics, Inc.
